Valuing the effect sizes hypothesized in phase 3 trials of targeted therapies in oncology

This abstract was not included in this publication as it was already published. See Annals of Oncology, Volume 27, Issue suppl_6, 1 October 2016, 317P (10.1093/annonc/mdw366.02) - Oxford University Press.

Opis bibliograficzny
Główni autorzy:	Reilly, G, Wise, A, Attwood, S, Scudder, C, Love, S
Format:	Conference item
Wydane:	BioMed Central 2017

Podobne zapisy

The changing world of clinical trials 2003-2017: A view from the AspECT trial
od: Reilly, G, i wsp.
Wydane: (2017)

Leveraging homologous hypotheses for increased efficiency in tumor growth curve testing
od: Alan D. Hutson, i wsp.
Wydane: (2023-11-01)

Conducting tests of hypotheses: the need for an adequate sample size
od: Mohd. Asraf, Ratnawati, i wsp.
Wydane: (2004)

Sample size determination for Bayesian ANOVAs with informative hypotheses
od: Qianrao Fu, i wsp.
Wydane: (2022-11-01)

THz therapy and smoking: facts and hypotheses
od: Svetlana S. Parshina
Wydane: (2013-11-01)

Vascular-targeted therapies in oncology /
od: Siemann, Dietmar W.
Wydane: (2006)

Size dimorphism and sexual segregation in pheasants: tests of three competing hypotheses
od: Mark A. Whiteside, i wsp.
Wydane: (2018-09-01)

Hypothèses
od: Christophe Blanquie

Statistical Fragility of Findings From Randomized Phase 3 Trials in Pediatric Oncology
od: Hannah E. Olsen, i wsp.
Wydane: (2024-12-01)

From the Hypotheses to Clinical Evidence in Retinal Therapy
od: Bradley Beatson, i wsp.
Wydane: (2021-05-01)

The value priority hypotheses for purchases of consumer durable goods
Wydane: (2003)

Acylglycerol Kinase-Targeted Therapies in Oncology
od: Binxiang Chu, i wsp.
Wydane: (2021-07-01)

Erythrocytes and NO: the facts and hypotheses interaction, prospects for diagnosis and therapy
od: M. V. Kruchinina, i wsp.
Wydane: (2014-09-01)

Modeling body size evolution in Felidae under alternative phylogenetic hypotheses
od: José Alexandre Felizola Diniz-Filho, i wsp.
Wydane: (2009-01-01)

The twin hypotheses
od: Howard, N
Wydane: (2013)

The Clash of Hypotheses
od: Vít Beneš
Wydane: (2005-12-01)

Regulatory T Cell-Targeted Immunomodulatory Therapy for Long-Term Clinical Improvement of Atopic Dermatitis: Hypotheses and Perspectives
od: Dong-Ho Nahm
Wydane: (2023-08-01)

Postprogression therapy and confounding for the estimated treatment effect on overall survival in phase III oncology trials
od: Pavlos Msaouel, i wsp.
Wydane: (2024-07-01)

Editorial: Targeted alpha particle therapy in oncology
od: Øyvind Sverre Bruland, i wsp.
Wydane: (2023-03-01)

The management of cancer in the elderly: targeted therapies in oncology
od: Usset Antonella, i wsp.
Wydane: (2008-12-01)

Immuno-Oncology: Emerging Targets and Combination Therapies
od: Henry T. Marshall, i wsp.
Wydane: (2018-08-01)

Update in Systemic and Targeted Therapies in Gastrointestinal Oncology
od: Nelson S. Yee
Wydane: (2018-03-01)

The Fisher hypotheses in Latin America: The Fisher hypotheses in Latin America
od: Antonio Ruiz Porras, i wsp.
Wydane: (2016-09-01)

Changing trends in phase 1 oncology clinical trials
od: Richard Kelly, i wsp.
Wydane: (2024-02-01)

Market size and export-led growth hypotheses: New evidence from Malaysia
od: Hassan, Sallahuddin, i wsp.
Wydane: (2016)

Market Size and Export-Led Growth Hypotheses: New Evidence from Malaysia
od: Sallahuddin Hassan, i wsp.
Wydane: (2016-07-01)

Market Size and Export-Led Growth Hypotheses: New Evidence from Malaysia
od: Sallahuddin Hassan, i wsp.
Wydane: (2016-05-01)

Multiple Hypotheses Testing Procedures in Clinical Trials and Genomic Studies
od: Qing ePan
Wydane: (2013-12-01)

Dental Hypotheses: Seeks to Publish Hypotheses from All Areas of Dentistry
od: Edward F. Rossomando
Wydane: (2010-07-01)

Dental Hypotheses: Seeks to Publish Hypotheses from All Areas of Dentistry
od: Edward F Rossomando
Wydane: (2010-01-01)

From <i>p</i>-Values to Posterior Probabilities of Null Hypotheses
od: Daiver Vélez Ramos, i wsp.
Wydane: (2023-04-01)

Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC)
od: James L Gulley, i wsp.
Wydane: (2022-09-01)

Phase 0 clinical trials in oncology new drug development
od: Umesh Chandra Gupta, i wsp.
Wydane: (2011-01-01)

Oncogenic activation of PIK3CA in cancers: Emerging targeted therapies in precision oncology
od: Yuxiang Wang, i wsp.
Wydane: (2025-03-01)

Hypotheses in Plato’s Meno
od: Judson, R
Wydane: (2017)

A computational method for prioritizing targeted therapies in precision oncology: performance analysis in the SHIVA01 trial
od: Istvan Petak, i wsp.
Wydane: (2021-06-01)

Testing statistical hypotheses /
od: Lehmann, E. L. (Erich Leo), 1917-
Wydane: (1959)

Genetic hypotheses for schizophrenia.
od: Crow, T
Wydane: (2007)